2022 Outlook: Notable FDA Approvals, Payer Strategies Are Specialty Trends
The specialty pharmacy industry will continue its growth in 2022, experts tell AIS Health, a division of MMIT. Multiple agents for rare diseases are poised for FDA approval, and the market may see additional cell and gene therapies. In addition, payers will carry on their efforts to keep prices for specialty medications affordable, among other trends.
AIS Health: What are some specialty pharmacy issues to keep an eye on in 2022, and why?